Results 91 to 100 of about 349,531 (370)

Report on Post-Quantum Cryptography

open access: yes, 2016
In recent years, there has been a substantial amount of research on quantum computers – machines that exploit quantum mechanical phenomena to solve mathematical problems that are difficult or intractable for conventional computers. If large-scale quantum
Lidong Chen   +6 more
semanticscholar   +1 more source

Cryptography - Lecture 3: Modern cryptography

open access: yes, 2022
Cryptography - Lecture 3: Modern cryptography This lecture is devoted to general description of basic ideas of the modern cryptography - block ciphers (DES, AES) and public key cryptography (secret transmission, electronic signature, key exchange and secret sharing schemes)
openaire   +2 more sources

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Counterfactual Quantum Cryptography

open access: yes, 2008
Quantum cryptography allows one to distribute a secret key between two remote parties using the fundamental principles of quantum mechanics. The well-known established paradigm for the quantum key distribution relies on the actual transmission of signal ...
C. H. Bennett   +5 more
core   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Indexing Properties of Primitive Pythagorean Triples for Cryptography Applications [PDF]

open access: yesarXiv, 2011
This paper presents new properties of Primitive Pythagorean Triples (PPT) that have relevance in applications where events of different probability need to be generated and in cryptography.
arxiv  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

A Hierarchical Authorization Reversible Data Hiding in Encrypted Image Based on Secret Sharing

open access: yesMathematics
In the current distributed environment, reversible data hiding in encrypted domain (RDH-ED) cannot grant corresponding privileges according to users’ identity classes.
Chao Jiang   +4 more
doaj   +1 more source

Practical device-independent quantum cryptography via entropy accumulation

open access: yesNature Communications, 2018
Device-independent cryptography goes beyond conventional quantum cryptography by providing security that holds independently of the quality of the underlying physical devices.
Rotem Arnon-Friedman   +4 more
semanticscholar   +1 more source

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

open access: yesMolecular Oncology, EarlyView.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy